| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 110.94B | 109.85B | 113.86B | 110.05B | 93.11B | 71.62B |
| Gross Profit | 13.40B | 13.40B | 14.34B | 15.76B | 14.06B | 12.33B |
| EBITDA | 10.87B | 10.75B | 11.56B | 12.70B | 11.29B | 10.03B |
| Net Income | 5.84B | 5.99B | 6.82B | 5.87B | 7.75B | 6.28B |
Balance Sheet | ||||||
| Total Assets | 103.15B | 103.22B | 103.13B | 102.36B | 99.99B | 90.04B |
| Cash, Cash Equivalents and Short-Term Investments | 6.34B | 7.69B | 9.79B | 8.08B | 8.84B | 8.70B |
| Total Debt | 19.54B | 20.39B | 23.33B | 20.41B | 20.44B | 20.17B |
| Total Liabilities | 52.11B | 52.14B | 54.87B | 56.80B | 57.84B | 53.87B |
| Stockholders Equity | 44.98B | 45.10B | 42.66B | 39.04B | 35.78B | 30.56B |
Cash Flow | ||||||
| Free Cash Flow | 2.67B | 3.56B | 3.12B | 3.86B | 4.21B | 4.18B |
| Operating Cash Flow | 9.67B | 10.29B | 9.61B | 10.10B | 10.47B | 9.70B |
| Investing Cash Flow | -5.55B | -4.44B | -4.85B | -5.73B | -6.77B | -6.49B |
| Financing Cash Flow | -5.85B | -7.86B | -3.14B | -5.02B | -3.64B | -1.90B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$74.19B | 12.01 | 12.60% | 4.30% | -3.19% | -2.68% | |
67 Neutral | HK$44.18B | 14.60 | 8.10% | 4.43% | -4.37% | -41.14% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
64 Neutral | HK$135.47B | 23.00 | 9.73% | 4.94% | 0.36% | 2.55% | |
63 Neutral | HK$39.61B | 7.70 | 5.14% | 6.44% | -2.28% | -9.61% | |
56 Neutral | HK$12.85B | 8.67 | 6.35% | 6.38% | 3.86% | 30.34% | |
48 Neutral | HK$7.31B | 30.75 | 2.04% | 0.71% | -7.82% | -38.06% |